Thanks for the reply Quiltman
You wrote,
But it could be that the move from OTC to prescription has eased the requirements from the Lead Reviewer somewhat.
So CDX are trying to gain clearance for prescription only ? Was this officially stated or communicated?
I think the prescription channel is a lot more lucrative and makes more sense initially with production.
- Forums
- ASX - By Stock
- CDX
- 2020
2020, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
0.003(3.80%) |
Mkt cap ! $24.12M |
Open | High | Low | Value | Volume |
8.4¢ | 8.6¢ | 8.0¢ | $26.90K | 328.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 57717 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 13790 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.080 |
1 | 57545 | 0.079 |
2 | 185000 | 0.078 |
1 | 156684 | 0.077 |
1 | 125000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 13790 | 1 |
0.083 | 29220 | 1 |
0.084 | 72059 | 1 |
0.088 | 382221 | 2 |
0.094 | 160250 | 2 |
Last trade - 13.44pm 01/11/2024 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |